Stratégie de dépistage du Covid-19 dans les entreprises vaudoises : quels enseignements ? [COVID-19 screening strategy in workplaces in the canton of Vaud: what lessons?]
Détails
Télécharger: 2022 VELEZ Dépistage COVID en entreprise VD quelles leçons RMS.pdf (174.59 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_AB2E61F7AB75
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Stratégie de dépistage du Covid-19 dans les entreprises vaudoises : quels enseignements ? [COVID-19 screening strategy in workplaces in the canton of Vaud: what lessons?]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
09/11/2022
Peer-reviewed
Oui
Volume
18
Numéro
803
Pages
2096-2100
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Repetitive screening in enterprises was one of the measures recommended in Switzerland in the fight against COVID-19. In the canton of Vaud, 70 companies participated in the program, 73 % of which were small and medium-sized enterprises. The SARS-CoV-2 positivity rate was 0.07 % out of 70'105 tests performed. The impossibility of teleworking and the reduction of transmission were the main motivations for joining the program. The facilitating elements were the availability of the Cantonal Medical Office, the existence of a starter kit and the support of the hierarchy within the companies. The main obstacles were the arrival of vaccination, the multiplicity of screening providers and the workload. The program was a pragmatic action tool for companies rather than a population-based strategy.
Mots-clé
Humans, Workplace, COVID-19/epidemiology, COVID-19/prevention & control, SARS-CoV-2, Mass Screening, Vaccination, Switzerland/epidemiology
Pubmed
Open Access
Oui
Création de la notice
20/01/2023 15:32
Dernière modification de la notice
06/05/2023 5:49